Joshua Corson
Analyst
H.C. Wainwright
Equibles does not estimate personal net worth.
About Joshua Corson
Joshua Corson is recorded as Analyst at H.C. Wainwright. Joshua Corson has spoken on 2 investor events across 2 companies, most recently for Fennec Pharmaceuticals Inc. on September 15, 2026. Those appearances were for Fennec Pharmaceuticals Inc. (FENC) and Lexicon Pharmaceuticals, Inc. (LXRX). The companies whose calls Joshua Corson spoke on are classified in the Healthcare sector.
Joshua Corson on recent calls
“And thank you for joining the H.C. Wainwright 28th Annual Global Investment Conference. My name is Joshua Corson, and I'm a Senior Equity Research Associate. Today, I would like to introduce our presenter, Robert Andrade, who is the CFO of Fennick Pharmaceuticals.”
“Good morning, everyone, and thank you for joining me at the H.C. Wainwright 28th Annual Global Investment Conference. My name is Joshua Corson, and I'm a Senior Equity Research Associate.”
Affiliation history
-
H.C. Wainwright
Analyst
Transcript header (unverified)
Current